Announcements Trials

Browse Landscape

Phase

Phase NA 42 Phase 2 2 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Lymphoid 2 Head & Neck 2 Breast 2 Tumor-Agnostic 1 Other 1 Gynecologic 1 Gastrointestinal 1 CNS 1

Conditions

Rectal Neoplasms 1

Interventions

Fluorouracil 308 Oxaliplatin 259 Leucovorin 233 Capecitabine 198 Irinotecan 145 Gemcitabine 127 Cisplatin 126 Bevacizumab 119 Radiotherapy 72 Paclitaxel 63 Folfox protocol 56 Cetuximab 56 Drug Therapy 46 Sorafenib 45 Docetaxel 41 S 1 (combination) 40 Chemotherapy, Adjuvant 38 Neoadjuvant Therapy 37 pembrolizumab 36 Surgical Procedures, Operative 27 130-nm albumin-bound paclitaxel 27 regorafenib 25 lenvatinib 24 XELOX 24 Panitumumab 24 Radiation 23 Nivolumab 22 trifluridine tipiracil drug combination 21 atezolizumab 21 Carboplatin 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Methods × Gastrointestinal × Clear all

NCT04288999 2020-06-04

JCOG1801

National Cancer Center Hospital East

Phase 3 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡